These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 7344514)

  • 81. Introduction: DNA damage and repair.
    Magee PN
    Basic Life Sci; 1983; 24():497-508. PubMed ID: 6860272
    [No Abstract]   [Full Text] [Related]  

  • 82. Comparison of carcinogenic potency across life stages: implications for the assessment of transplacental cancer risk.
    Dzubow R; Fields C; Ginsberg G; Sandy M; Mabson M; Foos B
    J Toxicol Environ Health A; 2019; 82(13):769-787. PubMed ID: 31402766
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Threshold and non-threshold chemical carcinogens: A survey of the present regulatory landscape.
    Bevan RJ; Harrison PTC
    Regul Toxicol Pharmacol; 2017 Aug; 88():291-302. PubMed ID: 28119000
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Carcinogens in food: priorities for regulatory action.
    McDonald AL; Fielder RJ; Diggle GE; Tennant DR; Fisher CE
    Hum Exp Toxicol; 1996 Sep; 15(9):739-46. PubMed ID: 8880209
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Protein adducts in the molecular dosimetry of chemical carcinogens.
    Skipper PL; Tannenbaum SR
    Carcinogenesis; 1990 Apr; 11(4):507-18. PubMed ID: 2182215
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The early detection of frameshift mutations induced by a food-borne carcinogen in rats: a new tool for molecular epidemiology.
    Burnouf DY; Fuchs RP
    Mutat Res; 2000 Apr; 462(2-3):281-91. PubMed ID: 10767638
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Carcinogen-macromolecular adducts as biomarkers in human cancer risk assessment.
    Hsia MT
    Biomed Environ Sci; 1991 Jun; 4(1-2):104-12. PubMed ID: 1910588
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Food-Borne Chemical Carcinogens and the Evidence for Human Cancer Risk.
    Kobets T; Smith BPC; Williams GM
    Foods; 2022 Sep; 11(18):. PubMed ID: 36140952
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Genotoxic carcinogenic risk of a new non-tobacco-burning cigarette.
    Rosenkranz HS; Ennever FK
    Mutagenesis; 1989 Sep; 4(5):377-80. PubMed ID: 2687633
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Environmental carcinogenesis: an integrative model.
    Trosko JE; Chang CC
    Q Rev Biol; 1978 Jun; 53(2):115-41. PubMed ID: 362470
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Use of covalent binding in risk assessment.
    Greim H
    Adv Exp Med Biol; 2001; 500():715-22. PubMed ID: 11765018
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Risk assessment for possible carcinogens: a critical look.
    Farber E
    Drug Metab Rev; 2000 May; 32(2):143-51. PubMed ID: 10774771
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Carcinogens in the diet vs. overnutrition. Individual dietary habits, malnutrition, and genetic susceptibility modify carcinogenic potency and cancer risk.
    Lutz WK
    Mutat Res; 1999 Jul; 443(1-2):251-8. PubMed ID: 10415443
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Short-term in vivo testing to discriminate genotoxic carcinogens from non-genotoxic carcinogens and non-carcinogens using next-generation RNA sequencing, DNA microarray, and qPCR.
    Furihata C; Suzuki T
    Genes Environ; 2023 Feb; 45(1):7. PubMed ID: 36755350
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cellular responses to carcinogen-induced DNA damage and the role of DNA repair.
    Roberts JJ
    Br Med Bull; 1980 Jan; 36(1):25-31. PubMed ID: 7020826
    [No Abstract]   [Full Text] [Related]  

  • 96. Binding of the carcinogen 2-acetamidophenanthrene to rat liver nucleic acids: lack of correlation with carcinogenic activity, and failure of the hydroxamic acid ester model for in vivo activation.
    Scribner JD; Koponen G
    Chem Biol Interact; 1979 Dec; 28(2-3):201-9. PubMed ID: 95104
    [No Abstract]   [Full Text] [Related]  

  • 97. Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling.
    van Delft JH; van Agen E; van Breda SG; Herwijnen MH; Staal YC; Kleinjans JC
    Carcinogenesis; 2004 Jul; 25(7):1265-76. PubMed ID: 14963013
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Deficiencies in the covalent binding index (CBI) for expressing in vivo binding to DNA with respect to predicting chemical carcinogenicity. A proposal for a target-organ binding index.
    Dashwood RH; Combes RD
    Mutat Res; 1987 Mar; 190(3):173-5. PubMed ID: 3821777
    [No Abstract]   [Full Text] [Related]  

  • 99. The time to tumor approach in risk assessment.
    Albert RE
    Basic Life Sci; 1986; 38():551-6. PubMed ID: 3741347
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Cancer and non-cancer risk assessment: not so different if you consider mechanisms.
    Conolly RB
    Toxicology; 1995 Sep; 102(1-2):179-88. PubMed ID: 7482552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.